These patterns may indicate a separate gastrointestinal condition unrelated to GLP-1 therapy, or they may warrant a temporary dose reduction or switch to a different formulationoral semaglutide sometimes produces different digestive responses than injection, for example
The longer the stool remains in the colon, the harder it becomes
Treede RD, Jensen TS, Campbell JN, et al
Symptoms may include blurred vision, floaters, or spots
Many pharmaceutical manufacturers implement temperature monitoring systems with automated alarms to detect any deviations from acceptable storage ranges, preventing costly losses from equipment failures or power outages
Semaglutide Semaglutide is a medication originally developed for the treatment of type 2 diabetes , but it has gained popularity for its use in weight management